The compared groups presented similar rates for the previous-to-stroke medication, including antiplatelets (active group 42%, control group 39%, p=0.73), anticoagulants (18% versus 11%, p=0.18), antihypertensives (82% versus 72%, p=0.39), oral antidiabetics (16% versus 18%, p=0.81), insulin (1.8% versus 7.4%, p=0.26), and statins (11% versus 7.4%, p=0.55). The gene discussed is INS; the disease is stroke disorder.